Transparency in Health and Health Care in the United States - Title page

pp iii-iii

Copyright page

pp iv-iv

Dedication

pp v-vi

Contents

pp vii-x

Contributors

pp xi-xiv

Acknowledgments

pp xv-xvi

Introduction

pp 1-12

Part I - Transparency in Health and Health Care: Thematic Issues

pp 13-68

Introduction to Part I

pp 15-16

1 - Smashing into Windows

pp 17-29

2 - The Interplay of Privacy and Transparency in Health Care

pp 30-43

3 - Transparency Trade-offs

pp 44-57

4 - Slightly Hazy

pp 58-68

Part II - Transparency and Informed Consent

pp 69-114

Introduction to Part II

pp 71-74

5 - Transparency versus Informed Consent

pp 75-87

6 - Transparency and Financial Conflicts

pp 88-102

7 - Making Religion Transparent

pp 103-114

Part III - Transparency and Economics: Health Care Costs and Billing

pp 115-178

Introduction to Part III

pp 117-120

8 - Transparency on Prescription Drug Research Expenditures

pp 121-131

9 - Is Pharmaceutical Price Transparency an Effective Means to Reduce High Prices and Wide Variations?

pp 132-152

Appendix 1 - Walgreens Generic Drug Pricing

pp 149-150

Appendix 2 - Rite Aid Generic Prices

pp 151-152

10 - Price Transparency

pp 153-164

11 - Solving Surprise Medical Bills

pp 165-178

Part IV - Transparency and Innovation

pp 179-226

Introduction to Part IV

pp 181-184

12 - Increasing the Transparency of FDA Review to Enhance the Innovation Process

pp 185-195